Limulus Amebocyte Lysate (LAL) Can Now Be Produced Without Harvesting the Blood of ~800,000 Horseshoe Crabs Each Year, Which Will Help Restore Their Natural Population
Read Press ReleaseSingle-use bioreactors market is estimated to attain a CAGR of 20.2% through 2027 owing to various advantages such as reduced cross contamination, cost-effectiveness, flexibility and increased productivity.
Read Press ReleaseThe Phase 2 study will assess the safety and efficacy of Longeveron's stem cell treatment under Japan's accelerated regulatory pathway for regenerative medicine.
Read Press ReleaseAASCP is hosting an FDA Panel and many distinguished physicians this weekend at their annual Scientific Congress. All physicians practicing stem cell treatments should not miss this event on Nov. 1-3, 2019.
Read Press ReleaseSafety Panel Discussion to be held at 3:00 p.m. on Nov. 2, 2019, moderated by Ms. Janet Marchbrody. Highly anticipated session will discuss the growing safety concerns of the industry.
Read Press ReleaseBreakthrough bioengineered, decellularized Wharton's Jelly matrix platform facilitates precision in vitro targeting of cancer stem cells (CSCs).
The Sanatela™ Matrix is a revolutionary, natural 3-D biomaterial that gives researchers a tool to cultivate and study stem cells, including cancer stem cells. This matrix tissue opens new research opportunities for the development of individualized cancer treatments in the lab and for High-Throughput Drug Screening applications by pharmaceutical and biotechnology companies.
Dr. Steven Victor Co-Author of "Stem Cells and Regenerative Therapies: Clarification of Terminology and Potential Applications in Aging and Neurodegenerative Disorders"
Read Press Release13th International Conference on Medical Regulation (IAMRA) in Association with the Dubai Health Regulation Conference 2018
Read Press ReleaseDr. Farshchian confirms the first meeting of The American Association of Stem Cell Physicians (AAOSCP) to spread the knowledge of therapeutics in Regenerative medicine.
Read Press ReleaseBioInformant is launching the "Market for Stem Cell Exosomes - Products, Services, & Technologies," a global strategic report targeting the growing demand for exosome therapeutics, diagnostics, and research tools.
Read Press Release